Late post-treatment 131I SPECT/CT reveals additional lymph node metastasis of papillary thyroid carcinoma
Nuklearmedizin - NuclearMedicine · 06.05.2026
DOI: 10.1055/a-2852-9891 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nuklearmedizin - NuclearMedicine, erschienen am 06.05.2026. Verfasst von Erik Karaskiwiecz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Dept. of Nuclear Medicine, RWTH Aachen University Hospital, Germany, Aachen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Dept. of Nuclear Medicine, RWTH Aachen University Hospital, Germany, Aachen.
- Center for Integrated Oncology (CIO), University Hospital Aachen, Germany, Aachen.
- Kliniken Maria Hilf GmbH, Academic Teaching Hospital of RWTH Aachen University, Germany, Mönchengladbach.
- Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Netherlands, Maastricht.
ORCID-Profile: Erik Karaskiwiecz
Zitieren
APA
Karaskiwiecz, E., Syka, A., Mottaghy, F. M., & Lütje, S. (2026). Late post-treatment 131I SPECT/CT reveals additional lymph node metastasis of papillary thyroid carcinoma. Nuklearmedizin - NuclearMedicine. https://doi.org/10.1055/a-2852-9891
Vancouver
Karaskiwiecz E, Syka A, Mottaghy FM, Lütje S. Late post-treatment 131I SPECT/CT reveals additional lymph node metastasis of papillary thyroid carcinoma. Nuklearmedizin - NuclearMedicine. 2026. doi:10.1055/a-2852-9891
BibTeX
@article{Karaskiwiecz2026,
author = {Karaskiwiecz, Erik and Syka, Arba and Mottaghy, Felix M and Lütje, Susanne},
title = {Late post-treatment 131I SPECT/CT reveals additional lymph node metastasis of papillary thyroid carcinoma},
journal = {Nuklearmedizin - NuclearMedicine},
year = {2026},
doi = {10.1055/a-2852-9891}
}
EUVIMED